An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats.

Abstract

Cetirizine hydrochloride was administered orally at 5 mg/cat, q24h, to 32 cats with allergic skin disease. Pruritus was reduced in 41% (13/32) of the cats. The antipruritic effect was repeatable and sustainable. There was no significant association between patient age, disease severity, or cutaneous reaction pattern and improvement during cetirizine administration. No adverse side effects were reported.

• Authors: Joya S Griffin, Danny W Scott, William H Miller Jr, Michelle M Tranchina
• Journal: The Canadian veterinary journal = La revue veterinaire canadienne (Can Vet J) Vol. 53 Issue 1 Pg. 47-50 (Jan 2012) ISSN: 0008-5286 [Print] Canada
• PMID: 22753962 (Publication Type: Journal Article)

Chemical References

• Antipruritics
• Cetirizine

Topics

• Administration, Oral
• Animals
• Antipruritics (administration & dosage, adverse effects, therapeutic use)
• Cat Diseases (drug therapy)
• Cats
• Cetirizine (administration & dosage, adverse effects, therapeutic use)
• Female
• Hypersensitivity (drug therapy, veterinary)
• Male
• Pruritus (drug therapy, veterinary)
• Treatment Outcome